PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
19-Jun-2023 UK NHS Trusts Challenged by Attack Surface Complexities Businesswire
19-Jun-2023 Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study Businesswire
19-Jun-2023 Signing of the Definitive Agreements in Connection With the Acquisition by NOVO NORDISK of a Controlling Stake in BIOCORP Businesswire
19-Jun-2023 PharmaNest to Present Six Digital Pathology Abstracts at the International Liver Congress-EASL 2023, Including Liver Related Clinical Outcomes Prediction Results in NASH Newswire
18-Jun-2023 Vaxxas Opens World-Class Manufacturing Facility To Produce Proprietary Needle-Free Vaccine Patch For Late-Stage Clinical Trials and First Commercial Products Businesswire
17-Jun-2023 Seres Therapeutics and Nestlé Health Science Present Late-Breaking Data on VOWST™, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection in Adults, at ASM Microbe 2023 Businesswire
17-Jun-2023 Takeda y HUTCHMED anuncian publicación de los resultados de la fase 3 del estudio FRESCO-2 en The Lancet Businesswire
17-Jun-2023 Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel) Delivers Deep and Durable Responses in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma in TRANSCEND Clinical Trials Presented at ICML 2023 Businesswire
17-Jun-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of John Wiley & Sons, Inc. (WLY) on Behalf of Investors Businesswire
17-Jun-2023 Lannett Successfully Emerges From Chapter 11 in Significantly Stronger Financial Position as the Company Remains on Track Toward Commercialization of Highly Promising Pipeline Businesswire
16-Jun-2023 Takeda y HUTCHMED anuncian la presentación de la solicitud para la autorización de comercialización de fruquintinib para el tratamiento colorrectal metastásico con tratamiento previo con la validación de la Agencia Europea de Medicamentos Businesswire
16-Jun-2023 ZYUS Life Sciences Announces Final Approval to Commence Trading on June 19, 2023, and Engages Independent Trading Group (“ITG”) as Market Maker Businesswire
16-Jun-2023 Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Businesswire
16-Jun-2023 Merck Completes Acquisition of Prometheus Biosciences, Inc. Businesswire
16-Jun-2023 Global Pulmonary Arterial Hypertension (PAH) Industry Research 2023 - ResearchAndMarkets.com Businesswire
16-Jun-2023 Global Genome Editing Market Report 2023: Players Include Sangamo Therapeutics, Precision Biosciences, Cellectis, Merck and Lonza - ResearchAndMarkets.com Businesswire
16-Jun-2023 Number of Shares and Voting Rights of ADOCIA as of May 31st, 2023 Businesswire
16-Jun-2023 Late-Breaking Results of a Preclinical Efficacy Study Presented at ENDO 2023 Show Seraxis SRE Sustainably Reverses Type-1-Diabetes Hyperglycemia Newswire
16-Jun-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors Businesswire
16-Jun-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Futu Holdings Limited (FUTU) on Behalf of Investors Businesswire